FDA updates potential risks with liquid-filled intragastric balloonsThere were no deaths reported in the Orbera and ReShape post-approval studies; however, it should be noted that neither of the studies...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure2 days ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity2 days ago